Eylea Eye Injection: What It Treats, Procedure, Risks & Cost

Eylea is an in-office eye injection (anti-VEGF medicine aflibercept) that slows or halts vision loss from wet age-related macular degeneration, diabetic macular oedema and several other retinal diseases. Ophthalmologists favour it because it targets the underlying leakage in the retina, often stabilising vision after the very first course. Millions of doses given worldwide confirm its safety profile, and most patients describe the procedure as quick and virtually painless.

Whether you have been advised to start injections, or you’re simply researching options for a family member, reliable details matter. In the sections that follow we explain who benefits from Eylea, how the injection is delivered, what it feels like, side-effects to watch for, how often you may need top-ups, and how much the treatment really costs in Australia. Practical after-care tips, alternatives such as Lucentis or Avastin, and a clear look at Medicare and private insurance rebates will help you decide with confidence. Let’s begin by understanding exactly how aflibercept works inside the eye.

Understanding Eylea (aflibercept) and the Conditions It Treats

Eylea is the trading name for the molecule aflibercept, a laboratory-engineered protein that binds and inactivates vascular endothelial growth factor-A and ‑B (VEGF) as well as placental growth factor. Blocking these signals prevents new leaky vessels from sprouting in the macula and stops existing vessels from oozing fluid. Developed by Regeneron and licensed to Bayer, the drug gained Therapeutic Goods Administration (TGA) approval in August 2012 and was first added to the Pharmaceutical Benefits Scheme (PBS) for wet age-related macular degeneration (wAMD) in December 2012. Subsequent PBS listings followed for retinal vein occlusion (2014), diabetic macular oedema (2015) and myopic choroidal neovascularisation (2020). Because it is delivered directly into the vitreous cavity, systemic exposure is tiny; the effect, however, is dramatic where it counts—at the retina.

Aflibercept sits in the anti-VEGF class alongside ranibizumab (Lucentis), bevacizumab (Avastin) and faricimab (Vabysmo). What sets Eylea apart is its high binding affinity and longer dwell time, allowing many patients to stretch injections to eight-weekly or even twelve-weekly intervals after the initial loading phase.

How Eylea Works Inside the Eye

VEGF is a normal growth signal the body uses to create blood vessels. In certain retinal diseases that signal goes haywire, causing fragile, abnormal vessels to invade the macula. These vessels leak blood and fluid, distorting the light-sensing cells and rapidly blurring central vision.

When an ophthalmologist performs an Eylea eye injection, 2 mg of aflibercept is placed into the gel (vitreous) that fills the eye. From there it diffuses to the retina, saturates free VEGF molecules and starves those rogue vessels of their growth message. The medicine hangs around for roughly four to eight weeks; once VEGF levels start to rise again, another injection is necessary to keep the disease suppressed. Because the dose stays inside the eye, overall blood levels are extremely low, reducing systemic side-effects compared with older, intravenous cancer formulations of anti-VEGF agents.

Approved Indications in Australia

The TGA and PBS currently recognise aflibercept for four sight-threatening retinal conditions:

• Wet (neovascular) age-related macular degeneration
• Diabetic macular oedema (DMO) and proliferative diabetic retinopathy
• Vision loss secondary to central or branch retinal vein occlusion (CRVO/BRVO)
• Myopic choroidal neovascularisation (mCNV)

Evidence for each indication comes from large randomised trials:

• VIEW 1 & VIEW 2: demonstrated equivalent or better visual outcomes to monthly Lucentis in wAMD
• VIVID & VISTA: confirmed meaningful vision gains in DMO
• COPERNICUS & GALILEO: showed rapid fluid resolution and acuity improvement in CRVO
• MYRROR: supported use in pathologic myopia

Being on the PBS means eligible Australian patients pay only the concessional or general co-payment for the drug itself, rather than the eye-watering full list price of around $1,800 per vial.

Likely Outcomes and Success Rates

For most people the primary goal is to hold on to “legal driving” or “reading the newspaper” vision. Real-world registry data from Australia and New Zealand (Fight Retinal Blindness Project) mirror clinical-trial outcomes:

• Wet AMD: roughly 9 in 10 eyes maintain or improve vision over the first year; 3 in 10 gain ≥15 letters
• DMO: two-thirds of eyes gain at least one line of vision at 24 months
• RVO: visual acuity typically improves by three to four lines within six months of regular therapy
• mCNV: 60–70 % of eyes gain ≥10 letters after a short loading course

Earlier treatment is consistently linked with better results—waiting until vision has slipped below driving standard often means those lines cannot be fully regained. While some lucky patients can eventually stop injections, many will need maintenance top-ups every two or three months to keep their retina dry. The silver lining is that aflibercept does not build up toxicity; published series document eyes receiving 50 + injections over a decade with stable pressure, clear lenses and preserved macular structure.

By understanding which diseases respond and why, you are better placed to discuss a tailored treatment plan with your retina specialist. Up next: how to tell if you are personally a good candidate—or whether another option might suit you better.

Are You a Candidate? Eligibility, Contra-Indications & Alternatives

Before you roll up your sleeve ‑ or in this case look up at the ceiling – it helps to know whether an Eylea eye injection is likely to be offered, temporarily postponed, or swapped for another therapy. Your retina specialist makes the final call after imaging and a clinical exam, but the pointers below will let you arrive at the appointment armed with the right questions.

Diagnostic Tests That Confirm Need for Eylea

Several in-office tests measure exactly what is happening at the back of the eye and guide the decision to start aflibercept:

• Optical coherence tomography (OCT) – a painless scan that builds a cross-section of the retina in seconds. Swollen macula tissue or pockets of fluid show up as bright spaces, revealing how active the disease is and how well it responds over time.
• Fluorescein angiography – a dye is injected into an arm vein and photographed as it travels through retinal vessels. Areas that leak or new “choroidal” vessels take up the dye, confirming wet AMD, retinal vein occlusion or myopic CNV.
• Visual acuity charting – the familiar letter chart documents baseline sharpness; gaining or losing letters later is what determines success.
• Occasional extras such as indocyanine green angiography or wide-field photography may be ordered if the diagnosis is unclear.

If these tests show fluid or bleeding in the macula and no obvious contra-indication exists, Eylea usually rises to the top of the treatment list.

Who Should Avoid or Delay Treatment

Aflibercept is generally well tolerated, yet a few situations warrant caution or a short deferment:

• Active eye infection or severe inflammation (conjunctivitis, uveitis): injecting through a “dirty” ocular surface increases endophthalmitis risk.
• Recent major cardiovascular event – stroke or heart attack within the past three months. Anti-VEGF drugs marginally lower circulating VEGF levels; although evidence of harm is thin, specialists prefer to let the acute period pass.
• Pregnancy and breastfeeding – VEGF is involved in placental development. Most doctors postpone regular injections unless sight-threatening complications demand action, and then they discuss risks in detail.
• Uncontrolled glaucoma – a high eye pressure spike can follow any intravitreal injection; stabilise the pressure first.
• Known allergy to aflibercept, latex (plunger caps) or any excipient in the vial.

If any of these apply, flag them early. A short delay rarely affects long-term vision if caught promptly.

Alternative Therapies When Eylea Is Not Suitable

Modern retina care is a buffet, not a one-dish menu. When an Eylea eye injection is ruled out — or simply fails to dry the retina — your specialist may pivot to:

Choice depends on diagnosis, cost tolerance, driving distance to clinic and previous response. Many patients cycle through two or more agents over the years to keep the retina dry with the fewest visits.

Knowing where you sit on the eligibility spectrum avoids surprises and speeds up treatment, because every week counts when central vision is on the line.

The Intravitreal Injection Procedure: Step-by-Step Experience

Hearing the words “needle in the eye” is enough to make anyone squirm, yet patients almost always walk out saying, “That was nowhere near as bad as I’d imagined.” An Eylea eye injection takes about 10–15 minutes door-to-door, with the business end of the needle over in seconds. Plenty of local anaesthetic, strict sterile technique and a calm, well-rehearsed clinical team keep discomfort minimal and safety high. Below is a blow-by-blow account so you know exactly what to expect.

Pre-Injection Preparation

Your visit typically starts with a short vision test and, if required, an OCT scan to confirm that fluid is still present. The nurse or doctor will:

• Review your medical history and any new medications (e.g. blood thinners, antibiotics).
• Obtain verbal or written consent, outlining benefits, rare risks and after-care rules.
• Instil dilating drops if the retina needs another look.
• Numb the eye thoroughly with a series of topical anaesthetic drops or gel. Many clinics add a small anaesthetic-soaked pledget under the lower lid for extra comfort.
• Clean the lids and lashes using 5–10 % povidone-iodine – the brown antiseptic that kills surface bacteria faster than any antibiotic.
• Offer a mild oral sedative if you are particularly anxious (bring a driver if you accept).

No fasting is required, and you can take regular morning medications with a sip of water.

What Happens in the Treatment Room

You’ll lie back in a reclining chair or on a procedure bed beneath a microscope. A few key steps follow:

1. The doctor places a small plastic clip called a speculum to keep eyelids gently apart – it feels odd but not painful.
2. More anaesthetic drops are instilled, then a final iodine rinse.
3. You’ll be asked to look in a particular direction (usually up and out). This exposes the white of the eye where the injection goes, about 3–4 mm from the coloured iris.
4. The very fine 30-gauge needle passes through the sclera into the vitreous gel. Most patients describe a dull pressure or nothing at all; a sharp sting is rare and lasts less than a second.
5. The aflibercept is injected – 0.05 mL, equating to 2 mg of medicine. The whole needle time is under ten seconds.

Some people notice a swirling grey shadow or tiny bubble floating across their vision immediately after; that’s the injection air bubble and drug mixing, not a detached retina. It fades within a day or two.

Immediate Post-Injection Care

Once the needle is withdrawn, the speculum is removed and the doctor checks your eye pressure with gentle finger pressure or a quick tonometer reading. A lubricating or antibiotic drop is instilled, and you can blink normally.

Normal sensations during the first 24–48 hours include:

• Mild sandy or gritty feeling (like an eyelash).
• Bloodshot patch on the white of the eye – a harmless bruise that clears in a week.
• A small moving floater or bubble.

You’ll be reminded to:

• Avoid rubbing the eye, heavy lifting and bending strenuously for the rest of the day.
• Skip swimming pools, spas and eye make-up for 72 hours.
• Use preservative-free artificial tears every few hours if dryness or scratchiness occurs.
• Phone the clinic immediately if you develop severe pain, rapidly worsening blur, increasing floaters or pus-like discharge – red flags for infection or retinal detachment.

Most people can drive home if vision is clear, but bringing a friend is prudent if you’re dilated or anxious. Work and routine activities can resume the next day. By demystifying each step, the prospect of your first Eylea eye injection becomes far less daunting – and that peace of mind is half the battle won.

Treatment Schedule and Follow-Up Expectations

A single Eylea eye injection is rarely a one-and-done fix. Think of it more like topping up engine oil: the first few fills prime the system, after which you and your ophthalmologist stretch the intervals as the retina stays dry. A clear understanding of the timetable helps you plan work, driving and family commitments—and keeps the surprises (and urgent calls to the clinic) to a minimum.

Loading Phase vs Maintenance Phase

Most retinal diseases need a “loading phase”: three injections given four weeks apart (week 0, week 4, week 8). These closely-spaced doses quickly knock down VEGF, remove fluid and lock in early visual gains. Studies show eyes that complete the loading phase are far more likely to hit and keep reading or driving vision.

After the third shot your specialist will review the OCT scan. If the macula is dry, you shift to a treat-and-extend model:

• Extend by two weeks each visit—e.g. 6 → 8 → 10 → 12 weeks—provided no fluid returns.
• If fluid re-appears or vision slips, the interval is shortened one step.
• Some eyes plateau happily at 8 weeks; others cruise out to 12 or even 16 weeks between doses.

A handy calendar example for a textbook responder:

Monitoring Vision and Retina Health

Every injection visit includes:

1. Visual-acuity check with the chart.
2. OCT scan to look for sneaky pockets of fluid.
3. Brief eye pressure reading.

Between visits you are the early-warning radar. A laminated Amsler grid at home lets you test each eye in 10 seconds; new distortion, blank spots or blur warrant a same-day call. Smartphone apps can also log daily vision scores. Acting fast if changes crop up usually means a one-off extra injection rather than a vision-threatening relapse.

Duration of Therapy and When It Might Stop

How long will you need injections? The honest answer: it varies. Average courses run 18–24 months for vein occlusion or myopic CNV, while wet AMD and diabetic macular oedema often require longer-term maintenance. Treatment may pause when:

• The macula has stayed completely dry at 12-week gaps for a year.
• Further injections no longer improve or preserve vision (switching drug class may follow).
• Significant health events make ongoing therapy unsafe.

Regular audits with your specialist ensure the plan matches your retina’s behaviour, not a one-size-fits-all textbook schedule. In short, stick to the agreed timetable, keep an eye on your Amsler grid, and you’ll give each Eylea eye injection the best shot at protecting your sight.

Risks, Side Effects, and Safe Recovery

No medical procedure is completely risk-free, yet intravitreal aflibercept has one of the best safety records in ophthalmology. Millions of doses have been administered worldwide, and the vast majority of people walk out with nothing more than a mildly bloodshot eye that clears in a few days. Still, it is important to recognise what is normal, what is a red flag and how a few simple habits after an Eylea eye injection can slash the chance of problems.

Common, Short-Term Effects

These reactions are expected and settle without treatment or with basic home care:

• Grittiness or a feeling that something is in the eye — due to the antiseptic and speculum; use preservative-free lubricants every two hours on day 1, then as needed.
• Sub-conjunctival haemorrhage (red patch on the white of the eye) — painless and harmless; fades over 7–14 days.
• Small moving bubble or floater — usually air from the syringe; sinks below the line of sight within 48 h.
• Mild ache or headache — paracetamol or ibuprofen is fine unless your GP has advised otherwise.

Roughly one in three patients will notice at least one of the above, but fewer than 5 % need to phone the clinic for reassurance. Vision may be a touch blurred for several hours thanks to dilating drops, but should be back to baseline the next morning.

Serious but Rare Complications

True sight-threatening events occur in fewer than 1 in 2 000 injections, yet recognising them quickly matters:

Systemic complications such as stroke or heart attack have been studied extensively. The evidence points to no significant increase in risk over background rates, but ophthalmologists still monitor patients with very recent vascular events more closely.

Lifestyle Do’s & Don’ts After the Injection

The surface puncture seals within minutes, yet tiny bugs in water or on fingers can still sneak in. Follow these common-sense rules:

• Do not rub or press on the treated eye for 24 h.
• Skip swimming pools, hot tubs and the ocean for 72 h; showering from the neck down is fine, but tilt your head back if washing your hair.
• Avoid eye make-up, contact lenses and dusty gardening for three days.
• No heavy lifting or inverted yoga poses on day 1 — normal walking and light chores are OK.
• Use lubricating drops liberally and finish any antibiotic drops if prescribed.
• Keep the after-hours number handy; if in doubt, call. Retina doctors prefer a false alarm to a late presentation.

Most people can drive the next day provided vision meets legal requirements and there is no significant discomfort.

Long-Term Safety Profile

A common worry is “How many injections are too many?” Real-world registries from Australia and New Zealand show patients receiving 30–50 aflibercept shots over a decade with no toxin build-up, optic-nerve damage or accelerated cataract formation. Unlike steroid injections, anti-VEGF therapy does not cloud the lens or routinely raise eye pressure long term.

What about the rest of the body? Tiny quantities of the drug reach the bloodstream, but large meta-analyses have not demonstrated a statistically significant uptick in strokes, heart attacks or kidney problems. That said, your ophthalmologist will coordinate with your GP or cardiologist if you carry multiple vascular risk factors.

Bottom line: when weighed against the prospect of irreversible vision loss, the safety-to-benefit ratio of an Eylea eye injection is overwhelmingly favourable. Understanding the risks, spotting the red flags and respecting a few recovery rules will keep that ratio stacked in your favour.

Cost of Eylea Injections in Australia

Sticker shock is a common concern when the words “ongoing injections” appear on the treatment plan. The good news is that almost all Australians receive substantial government support, and with a little forward-planning the regular bill for an Eylea eye injection rarely jeopardises the weekly grocery shop. Below we unpack each layer of possible expense—from the PBS drug subsidy right through to private health rebates—so you can budget with realistic numbers instead of rumours.

PBS Coverage and Eligibility Criteria

Eylea (aflibercept 2 mg/0.05 mL) is listed on the Pharmaceutical Benefits Scheme as an Authority item for:

• Wet age-related macular degeneration
• Diabetic macular oedema and proliferative diabetic retinopathy
• Branch / central retinal vein occlusion
• Myopic choroidal neovascularisation

Your ophthalmologist must lodge an online Authority request (usually approved instantly) before writing the prescription. Once approved, the pharmacy invoices the Commonwealth for the majority of the $1 800-plus list price, leaving you to pay only the standard PBS co-payment:

• General patients: about $32 per vial (indexed 1 January each year)
• Concession card holders: about $7 per vial
• Safety-net: once you or your family hit the annual PBS cap, the co-payment falls to $0 for concession or to the concession amount for general patients.

The Authority is renewed every 6–12 months with proof—via OCT scan—that the medicine is still needed, a formality your retina specialist handles at each review.

Out-of-Pocket Costs for Medicare Patients

Medicare covers the doctor’s professional fee through item 42738 – intravitreal injection (rebate ≈ $99 in 2025). Practices charge different schedules:

Add the PBS co-payment for the drug itself and the average private-room visit lands around $170–$260 for general patients, $60–$110 for concession card holders. Public hospital clinics usually bulk-bill everything except the PBS co-payment, but waiting lists and parking costs can offset the saving.

Private Health Insurance and No-Gap Options

Because Eylea is supplied under the PBS, private hospital cover does not pay for the drug. What it can absorb are facility and theatre fees if your injections are done in a day-surgery or hospital setting rather than in-rooms. Three common scenarios:

1. In-rooms (most common) – No facility fee, so insurance plays no role; you pay the doctor’s gap and PBS co-payment.
2. Day-surgery with no-gap agreement – Some insurers have contracts that wipe the theatre charge, leaving you with the PBS co-payment plus any doctor gap.
3. Known-gap agreement – The insurer pays a set amount, you cover an agreed excess (often $200–$400 per year, not per visit).

Ask the clinic where your injections are performed and whether they have “no-gap” arrangements with your fund.

Comparing Costs of Other Anti-VEGF Agents

Cost can tilt the choice of drug when medical efficacy is similar. A quick side-by-side:

*Drug cost only; procedure fees extra.
While compounded Avastin appears cheaper per vial, the lack of PBS subsidy means the final cost difference is often narrower than expected, especially for concession patients.

Financial Assistance and Support Programmes

Nobody should lose sight because of a price tag. If the figures above still stretch the budget, explore:

• Pharmaceutical company co-pay cards – Bayer/Regeneron occasionally run “first-dose free” or travel voucher schemes; ask the clinic nurse.
• Department of Veterans’ Affairs (DVA) – Gold Card holders have all gaps covered, including procedure fees.
• Closing the Gap (CTG) script – Subsidises PBS co-payment to $0 for eligible Aboriginal and Torres Strait Islander patients.
• Rural Patient Travel Subsidy – State-based schemes refund mileage or flights if you live a set distance from the retina clinic.
• NDIS & Vision Australia – May help with low-vision aids, transport, or social support while treatment stabilises.

Your ophthalmology practice’s reception team deals with these programmes daily; lean on their experience to complete the paperwork quickly.

Budgeting for an Eylea eye injection course is rarely painless, yet with PBS support, clear quotes and the right rebates most patients find the ongoing cost manageable—and consider it a worthwhile investment in keeping the driver’s licence, the quilting hobby, or simply the joy of reading grandchildren’s birthday cards unaided.

Preparing for Your First (or Next) Eylea Injection: Practical Tips

A little planning turns an unfamiliar medical visit into a straightforward pit-stop. The pointers below are distilled from what we tell patients every clinic day; use them to keep stress low, maximise comfort and avoid last-minute scrambles. They apply whether this is injection number one or number twenty-one.

Questions to Ask Your Ophthalmologist

• What is the specific goal for my eye at this stage of treatment?
• How soon after the Eylea eye injection should I notice stability or improvement?
• If fluid persists, what is the back-up plan—different interval, different drug, or extra imaging?
• What are today’s out-of-pocket costs, and how many visits are budgeted for the next six months?
• Who do I ring after hours if something feels wrong?

Having these answers written down (phone photo works too) avoids confusion later.

Logistics on Injection Day

• Arrange transport; dilating drops can blur vision for a few hours.
• Skip mascara and moisturiser around the lids—iodine sticks better to clean skin.
• Bring sunglasses; the world looks brighter after dilation.
• Pack a list of current medications, especially blood thinners.
• Allow at least one hour in the clinic: check-in, scan, injection, quick cuppa before heading home.

Coping with Anxiety and Discomfort

Needles make many people queasy, so try:

1. Slow nasal breathing—inhale for four counts, exhale for six—while lying back.
2. Plug in one earbud with a favourite track or podcast; we can work around it.
3. Ask for extra numbing gel or a mild oral sedative if previous injections stung or nerves ran high.

Remember, most describe only fleeting pressure, not pain.

At-Home Eye Care Between Injections

• Check the Amsler grid (or app) twice a week—report new distortion straight away.
• Keep blood sugar, blood pressure and cholesterol in target range; they influence VEGF levels.
• Load the plate with leafy greens, oily fish and nuts—retina-friendly fuel.
• Quit smoking; it halves the chance of needing more frequent injections.
• Stock preservative-free lubricants and use them whenever the eye feels gritty, computer work included.

With the right preparation an Eylea eye injection becomes another healthy habit, not a hurdle.

Frequently Asked Questions About Eylea Eye Injections

We hear the same queries in clinic every week, so we’ve gathered the short, evidence-based answers below. Skim them now, bookmark them for later, and feel free to raise anything else with your retina specialist.

What does Eylea actually do to the eye?

An Eylea eye injection delivers aflibercept into the vitreous gel, where it locks on to vascular endothelial growth factor (VEGF). By neutralising VEGF, it stops abnormal macular blood vessels from leaking or growing, allowing retinal swelling to subside and vision to stabilise—often within weeks.

How long does an Eylea injection last, and will I always need them?

The medicine remains active for roughly four to eight weeks. After an initial three-dose “loading” course, many eyes move to eight-, ten- or even twelve-week intervals. Some conditions (vein occlusion, myopic CNV) can stop after a year or two, but wet AMD and diabetic macular oedema usually need ongoing maintenance.

Is Eylea a steroid?

No. Aflibercept is an anti-VEGF biologic, not a corticosteroid. That means it avoids steroid-related complications such as cataract acceleration and long-term pressure rise, while still tackling swelling at its biochemical source.

What can I not do after an injection?

For 72 hours skip swimming, spas, eye make-up and dusty gardening, and avoid rubbing the treated eye. Heavy lifting and inverted yoga poses are best avoided for the first 24 hours. Normal showering, light walking and screen use are fine.

Are there long-term side effects?

Decade-long registries show no cumulative retina toxicity, and glaucoma or cataract rates are similar to untreated eyes. Serious infection (endophthalmitis) remains very rare—about one in 2 000 injections—provided post-injection care rules are followed. Systemic stroke or heart-attack risk has not been proven to increase significantly.

Eylea vs Avastin: which is better?

Head-to-head trials find both drugs equally effective at preserving vision. Eylea is purpose-made, PBS-listed and allows longer intervals, while Avastin is a repurposed cancer drug compounded into eye-sized doses and costs less up-front. Choice comes down to medical nuances, access and budget—your ophthalmologist will explain which fits your situation.

How much does each injection cost in Australia?

Under the PBS, patients pay about $32 per vial (or $7 with a concession card); the Commonwealth picks up the rest of the $1 800 list price. Add procedure and imaging gaps and the typical private-room visit totals $170–$260 for general patients, $60–$110 for concession holders. Public hospital clinics often bulk-bill the procedure, leaving only the PBS co-payment.

Key Takeaways on Eylea Eye Injections

Still weighing up whether the jab is worth it? Here’s the short version:

• Sight-saving medicine – Eylea (aflibercept) is an anti-VEGF injection that targets leaking retinal vessels, preserving or improving vision in wet AMD, diabetic macular oedema, retinal vein occlusion and myopic CNV.
• Fast, low-fuss procedure – The appointment takes less than 15 minutes door-to-door and is virtually painless thanks to strong numbing drops and strict sterile technique.
• Manageable schedule – After the initial three-dose loading phase, most eyes stretch to 8–12-week maintenance intervals, guided by OCT scans and day-to-day vision checks.
• Excellent safety profile – Minor grittiness or redness is common; serious events such as infection occur in fewer than 0.05 % of injections, keeping the risk–benefit balance firmly in your favour.
• Clear, affordable pricing – With PBS support each visit usually costs $170–$260 for general patients and under $110 for concession card holders—small change compared with the cost of losing driving or reading vision.

If you’re in Sydney’s Eastern Suburbs and want personalised guidance, book a consultation with Bright Sight Eye Specialists via our Randwick clinic.